Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 7, 2024; 30(5): 471-484
Published online Feb 7, 2024. doi: 10.3748/wjg.v30.i5.471
Published online Feb 7, 2024. doi: 10.3748/wjg.v30.i5.471
Figure 3 Recombinant adeno-associated virus 8 mediated anti-let-7a-5p protects from 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine-induced hepato-biliary damages.
A: The ratio of Liver weight to body weight; B-E: Serum levels of aspartate aminotransferase, total bilirubin, alanine aminotransferase, and alkaline phosphatase in the normal control, scramble control, and anti-let-7a sponge (anti-let-7a-5p) mice for 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine feeding at the indicated time (2 wk and 6 wk). DDC: 3,5-Diethoxycarbonyl-1,4-Dihydrocollidine; SCR: Scramble control; AST: Aspartate aminotransferase; BILT: Total bilirubin; ALT: Alanine aminotransferase; ALP: Alkaline phosphatase; TBA: Total bile acid. aP < 0.05, bP < 0.01, cP < 0.001.
- Citation: Hua H, Zhao QQ, Kalagbor MN, Yu GZ, Liu M, Bian ZR, Zhang BB, Yu Q, Xu YH, Tang RX, Zheng KY, Yan C. Recombinant adeno-associated virus 8-mediated inhibition of microRNA let-7a ameliorates sclerosing cholangitis in a clinically relevant mouse model. World J Gastroenterol 2024; 30(5): 471-484
- URL: https://www.wjgnet.com/1007-9327/full/v30/i5/471.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i5.471